These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer. Martin YN; Olson JE; Ingle JN; Vierkant RA; Fredericksen ZS; Pankratz VS; Wu Y; Schaid DJ; Sellers TA; Weinshilboum RM Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2322-4. PubMed ID: 17119067 [No Abstract] [Full Text] [Related]
26. Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort. Henderson KD; Goran MI; Kolonel LN; Henderson BE; Le Marchand L Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2298-302. PubMed ID: 17119061 [TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor I in pregnancy and maternal risk of breast cancer. Lukanova A; Toniolo P; Zeleniuch-Jacquotte A; Grankvist K; Wulff M; Arslan AA; Afanasyeva Y; Johansson R; Lenner P; Hallmans G; Wadell G; Lundin E Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2489-93. PubMed ID: 17132766 [TBL] [Abstract][Full Text] [Related]
28. IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study. Deming SL; Ren Z; Cai Q; Shu XO; Wen W; Long JR; Gao YT; Zheng W Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):255-7. PubMed ID: 18199734 [No Abstract] [Full Text] [Related]
29. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer. Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664 [TBL] [Abstract][Full Text] [Related]
30. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M; Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421 [TBL] [Abstract][Full Text] [Related]
31. The fallacy of racial medicine: confusions about human races. Lewontin RC Genewatch; 2005; 18(4):5-7, 17. PubMed ID: 16270429 [No Abstract] [Full Text] [Related]
32. Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes? Singh V; Parmar D; Singh MP Cancer Invest; 2008 Oct; 26(8):769-83. PubMed ID: 18798070 [TBL] [Abstract][Full Text] [Related]
33. Genome research: map of the human genome 3.0. Helmuth L Science; 2001 Jul; 293(5530):583-5. PubMed ID: 11474073 [No Abstract] [Full Text] [Related]
35. No significant association results obtained from significant association evidence: the ongoing uncertainty of TP53 codon 72 polymorphism and breast cancer risk. Lu PH; Tao GQ; Liu X; Li C; Wei MX Breast Cancer Res Treat; 2011 Jan; 125(2):601-3. PubMed ID: 20963481 [No Abstract] [Full Text] [Related]
37. Medically, race means nothing. Victoroff MS Manag Care; 2002 Apr; 11(4):23-4. PubMed ID: 11980222 [No Abstract] [Full Text] [Related]
38. [One, two, three...a thousand genomes?]. Jordan B Med Sci (Paris); 2008 Mar; 24(3):237-8. PubMed ID: 18334165 [No Abstract] [Full Text] [Related]
39. Human genomics: disclosure of variation. Nielsen R Nature; 2005 Mar; 434(7031):288-9. PubMed ID: 15772636 [No Abstract] [Full Text] [Related]
40. Genetics and ethnicity will play bigger roles in dietetics. Brown D J Am Diet Assoc; 2003 Feb; 103(2):207. PubMed ID: 12589327 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]